Herrmann 1990.
Methods | Randomized double blind placebo controlled study | |
Participants | Country: Germany Multicentre Selection criteria: mild to moderate cognitive decline corresponding to stages 3 or 4 on the Global Deterioration Scale (80% GDS stage 3) 230 male and female patients age 60‐80 years | |
Interventions | 1. ALC 1.5g/day for 12 weeks 2. Placebo for 12 weeks | |
Outcomes | CGI‐C, NGDAS, modified digit symbol substitution test. | |
Notes | Analysed completers, not intention to treat |